News
company
year
domain
Seres Therapeutics 10.02.2017
KSQ Therapeutics 10.02.2017
Indigo Agriculture 09.28.2017
Moderna 09.26.2017
09.26.2017
2017
Seres Therapeutics Reports Positive Topline Results from SER-287 Phase 1b Study in Patients with Ulcerative Colitis
KSQ Therapeutics Emerges With $76 Million In Financing To Pioneer High-Confidence Drug Development
Indigo Names Dr. Jonathan McIntyre as Head of R&D, Further Expanding Leadership Team
Moderna Announces Publication in Molecular Therapy Characterizing Potent Immune Response Generated by Its mRNA Prophylactic Vaccines
FierceBiotech Names Rubius Therapeutics as one of its “Fierce 15” Biotech Companies of 2017